Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

- Francis, Prudence A., Fleming, Gini F., Burstein, Harold J., Davidson, Nancy E., Geyer, Charles E., Walley, Barbara A., Ingle, James N., Coleman, Robert E., Müller, Bettina, Le Du, Fanny, Loibl, Sibylle, Winer, Eric P., Láng, István, Ruepp, Barbara, Loi, S, Colleoni, M, Coates, AS, Gelber, RD, Goldhirsch, A, Regan, MM, SOFT Investigators and the International Breast Cancer Study Group (a division of ETOP IBCSG Partners Foundation),, Ciruelos, Eva M., Bonnefoi, Hervé R., Bellet, Meritxell, Bernardo, Antonio, Climent, Miguel A., Martino, Silvana, Bermejo, Begoña

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

- Ribi, Karin, Luo, Weixiu, Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Colleoni, Marco, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L.